FOSAMAX PLUS and FOSAMAX PLUS D Re-examination Study (0217A-267)
Condition(s):OsteoporosisLast Updated:February 3, 2022Completed
Hide Studies Not Open or Pending
Condition(s):OsteoporosisLast Updated:February 3, 2022Completed
Condition(s):Spinal Cord Injury; OsteoporosisLast Updated:January 29, 2016Terminated
Condition(s):HealthyLast Updated:June 14, 2010Completed
Condition(s):Juvenile Osteoporosis; Low Bone Density; FracturesLast Updated:July 11, 2018Completed
Condition(s):HyperparathyroidismLast Updated:November 16, 2011Withdrawn
Condition(s):OsteoporosisLast Updated:March 18, 2021Completed
Condition(s):Osteopenia or OsteoporosisLast Updated:April 13, 2022Active, not recruiting
Condition(s):OsteoporosisLast Updated:May 31, 2022Recruiting
Condition(s):OsteoporosisLast Updated:January 19, 2011Completed
Condition(s):Osteoporosis PostmenopausalLast Updated:February 8, 2022Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.